Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-07

Clinical Trial Update: Altered Brain GABA and Glutamate in Restless Legs Syndrome

View source ↗

Summary

A completed clinical trial investigated alterations in brain GABA and glutamate levels in individuals with Restless legs syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Restless Legs Syndrome | Status: COMPLETED